Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity
Authors
Keywords
-
Journal
BIOTECHNOLOGY AND BIOENGINEERING
Volume 112, Issue 6, Pages 1102-1110
Publisher
Wiley
Online
2015-02-17
DOI
10.1002/bit.25537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells
- (2015) Eun-Ju Ko et al. Nanomedicine-Nanotechnology Biology and Medicine
- Immune responses to vaccines involving a combined antigen–nanoparticle mixture and nanoparticle-encapsulated antigen formulation
- (2014) Weifeng Zhang et al. BIOMATERIALS
- Resistance to human epidermal growth factor receptor type 2-targeted therapies
- (2014) Jean-Christophe Thery et al. EUROPEAN JOURNAL OF CANCER
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Allogeneic tumor cell vaccines
- (2013) Sanjay Srivatsan et al. Human Vaccines & Immunotherapeutics
- Chimeric Trop2 Virus-like Particles
- (2011) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development
- (2011) Rangaiah Shashidharamurthy et al. MEDICINAL RESEARCH REVIEWS
- Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles
- (2010) Jae-Min Song et al. VIROLOGY
- A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
- (2009) P. P. Peethambaram et al. CLINICAL CANCER RESEARCH
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes
- (2009) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells
- (2009) Sheng Zhang et al. MOLECULAR IMMUNOLOGY
- Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles
- (2009) Sang-Moo Kang et al. PLoS One
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- The E75 HER2/neu peptide vaccine
- (2008) Elizabeth A. Mittendorf et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
- (2008) Peter S. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine
- (2008) Jarrod P. Holmes et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started